Charting the Future of Aesthetic Medicine
Ep. 197 w/ Bob Rhatigan of Merz Aesthetics
28 minute view/listen
Sep 2025
Available everywhere you podcast
What does it take to lead a global aesthetics company into the next decade of innovation?
On this episode of The Technology of Beauty, Dr. Grant Stevens welcomes Bob Rhatigan, the CEO of Merz Aesthetics, for a revealing look at the company’s rapid evolution and bold ambitions.
From his early days at Procter & Gamble and Allergan to leading Merz’s global transformation, Bob shares a journey that spans decades of shaping consumer health and medical aesthetics. He discusses Merz’s newly approved technologies, including the next-generation Ultherapy® Prime, an expanded HA filler portfolio, and a booming bio-stimulator category with Radiesse®. With over 30 R&D projects in the pipeline and 20 slated to launch within five years, Merz is doubling down on its future.
The conversation also explores broader industry dynamics, including Bob’s perspective on mergers and acquisitions, the role of safety-enhancing technologies, and how consumer expectations are shifting toward younger patients and home-based treatments. Bob also opens up about the next frontiers of the industry—from regenerative aesthetics and exosomes to emerging safety technologies and predictive diagnostics.
If you want a front-row seat to where the industry is heading, this is one conversation you won’t want to miss.
Subscribe to
The Technology of Beauty
Produced and co-founded by Influx, The Technology of Beauty is the podcast of renowned plastic surgeon Dr. Grant Stevens. Tune in to hear interviews with the innovators and entrepreneurs who are shaping the future of aesthetics from the industry side.
